The news of Benchmark analyst Robert Wasserman reiterating a Buy rating on Proto Labs and maintaining a $45 price target is positive for the company's stock. This reaffirms the analyst's confidence in the company's performance and potential growth, which could lead to an increase in investor interest and a short-term positive impact on the stock price.